Alcami
- Company typePrivate
- Founded1981
- HeadquartersWilmington, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
Alcami firmographics
Firmographics- Name
- Alcami
- Legal name
- Alcami Corporation
- Website
- https://alcami.com
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Alcami industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing (CDMO)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)
- akta.pro secondary industries
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ), Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where Alcami is headquartered
LocationHeadquarters
- HQ city
- Wilmington
- HQ country
- United States
- HQ region
- North America
Offices15 records
Markets served
Alcami business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Contract Development & Manufacturing (CDMO) Services: Alcami generates revenue primarily through project-based contracts for integrated pharmaceutical manufacturing and development services, including sterile fill-finish, oral solid dose manufacturing, laboratory testing, and cGMP storage. Contracts are structured as multi-year service agreements or standalone project engagements, with pricing based on scope, scale, and complexity of manufacturing or testing requirements.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Alcami product offering
Product offeringCore offering
Alcami is a U.S.-based Contract Development and Manufacturing Organization (CDMO) that provides fully integrated pharmaceutical services across three core pillars: Drug Product Manufacturing (sterile fill-finish, oral solid dose, packaging and labeling, formulation development), Laboratory Services (analytical method development, microbiology, compendial testing, biologics, extractables and leachables, nitrosamines, stability, ICP-MS), and cGMP Pharma Storage and Support Services (cryogenic storage, metrology and calibration, CQV, environmental monitoring, on-site services). The company serves pharmaceutical and biotech clients from preclinical development through commercial supply.
Product overview
Alcami is a U.S.-based Contract Development and Manufacturing Organization (CDMO) providing fully integrated pharmaceutical services across three core service pillars: Drug Product Manufacturing (sterile fill-finish, oral solid dose, packaging & labeling, and formulation development), Laboratory Services (analytical method development, microbiology, compendial testing, biologics, E&L testing, nitrosamines testing, stability storage, ICP-MS, and food interaction studies), and Pharma Storage & Services (cGMP storage, cryogenic storage, metrology & calibration, CQV, environmental monitoring, on-site services, and materials management). The company operates over 1 million square feet across the U.S. and Europe, supporting pharmaceuticals and biologics from preclinical development through commercial supply. The acquisition of Tjoapack in 2026 expanded their capabilities to include European Qualified Person (QP) release services and transatlantic packaging scale.
Differentiator
Problem solved
Functional benefit
Products and services
- Sterile Fill-Finish Manufacturing
- Oral Solid Dose Manufacturing
- Packaging & Labeling
- Formulation Development
- Analytical Method Development
- Microbiology Testing
- Compendial Testing
- Biologics Services
- Extractables & Leachables Testing
- Nitrosamines Testing
- Stability Testing & Storage
- ICP-MS Capabilities
- Food & Drug Interaction Studies
- cGMP Pharma Storage
- Cryogenic Storage
- Metrology & Calibration
- Commissioning, Qualification & Validation (CQV)
- Environmental Monitoring & Cleanroom
- On-Site Pharma Services
- Pharmaceutical Materials Management
Quantifiable outcome
- Supports production of over 80 commercial products worldwide
- +4 more outcomes
Companies that use Alcami
Customer profileSegments3 records
Ideal customer profiles3 records
Alcami technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature8 records
Alcami partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship and core.
- TjoapackflagshipAlcami agreed to acquire Tjoapack (announced April 2026, completed May 2026), a global contract packaging organization with facilities in the U.S. and the Netherlands. The acquisition creates an end-to-end global CDMO platform with U.S.-Europe supply chain redundancy. Tjoapack customers gain access to Alcami's drug product manufacturing, laboratory services, and pharma storage; Alcami customers gain expanded packaging scale, supply chain redundancy, and QP release services in Europe.
- Pacific Pharmaceutical ServicescoreAlcami acquired Pacific Pharmaceutical Services in January 2024 to enhance its West Coast presence and analytical testing capabilities. The acquisition added cGMP pharma storage and services on the West Coast, expanding Alcami's geographic network across the Northeast, Southeast, and West Coast of the U.S.
Scale indicators10 records
Recent moves10 records
Expansion highlights6 records
Alcami competitors and assessment
Company assessmentBroad incumbents
- Eurofins CDMO: Eurofins' CDMO arm provides pharmaceutical contract development, manufacturing, and laboratory services globally. Direct overlap with Alcami's analytical laboratory services, microbiology, and compendial testing offerings.
- Catalent: Catalent is the largest standalone CDMO globally, offering sterile fill-finish, oral solid dose, biologics, and softgel capabilities across a much broader network. Direct overlap with Alcami in sterile fill-finish and OSD makes it the most comparable scaled incumbent.
- Lonza Group: Lonza is the global leader in biologics CDMO and a major small-molecule API manufacturer. Direct competitor for Alcami's biologics analytical services and sterile fill-finish capacity, with materially greater scale and biologics depth.
- Thermo Fisher Scientific (Patheon CDMO): Thermo Fisher's Patheon segment offers integrated drug substance, drug product, clinical trial materials, and packaging services globally. Overlaps with Alcami across nearly every service line and represents the type of large strategic that could be a future acquirer or competitor.
- Samsung Biologics: Samsung Biologics is a leading global biologics CDMO with large-scale mammalian cell culture capacity. Comparable to Alcami's growing biologics analytical and cell bank storage services, though substantially larger and more focused on biologics drug substance.
Direct peers
- PCI Pharma Services: PCI is a closely comparable integrated CDMO focused on clinical and commercial packaging, sterile fill-finish, and global supply chain services. Direct overlap with Alcami's packaging, sterile fill-finish, and biopharma storage services, and similar in scale and PE-backed status.
- Siegfried Holding: Siegfried is a Swiss-listed CDMO providing API and finished drug product manufacturing (sterile and OSD) with similar mid-market positioning. Direct overlap with Alcami's small-molecule OSD and parenteral fill-finish services.
- Recipharm: Recipharm is a European-headquartered CDMO providing sterile fill-finish, OSD, and API services with global reach. Direct competitor for Alcami's Tjoapack-enabled European footprint and similar mid-market positioning.
- Delpharm: Delpharm is a leading European CDMO providing sterile injectable and OSD manufacturing services across multiple sites. Comparable to Alcami's European operations post-Tjoapack and a competing option for European pharma clients.
Emerging players
- Avid Bioservices: Avid Bioservices is a mid-market biologics CDMO focused on mammalian cell culture, fill-finish, and process development. Alcami's Chief Strategy Officer previously served as Avid's CCO, indicating executive familiarity. Comparable mid-market CDMO with biologics focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Alcami social profiles
Digital presenceAlcami compliance and trust
Trust signalCompliance2 records
Alcami financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alcami leadership team
Management profileNumber of profiles
Profiles11 records
Alcami subsidiaries and ownership
Company hierarchySubsidiaries3 records
Alcami funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alcami M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alcami
What does Alcami do?
Alcami is a U.S.-based Contract Development and Manufacturing Organization (CDMO) that provides fully integrated pharmaceutical services across three core pillars: Drug Product Manufacturing (sterile fill-finish, oral solid dose, packaging and labeling, formulation development), Laboratory Services (analytical method development, microbiology, compendial testing, biologics, extractables and leachables, nitrosamines, stability, ICP-MS), and cGMP Pharma Storage and Support Services (cryogenic storage, metrology and calibration, CQV, environmental monitoring, on-site services). The company serves pharmaceutical and biotech clients from preclinical development through commercial supply.
Is Alcami a public or private company?
Alcami is a private company. It is classified as private equity controlled and is currently operating.
When was Alcami founded?
Alcami was founded in 1981. It employs 501 to 1,000 people.
Where is Alcami based?
Alcami is headquartered in Wilmington, United States, in the North America region.
How does Alcami make money?
One revenue line is on record: contract Development & Manufacturing (CDMO) Services.
Who are Alcami's main competitors?
Broad incumbents on record are Eurofins CDMO, Catalent, Lonza Group, Thermo Fisher Scientific (Patheon CDMO) and Samsung Biologics. Direct peers are PCI Pharma Services, Siegfried Holding, Recipharm and Delpharm. Avid Bioservices is listed as an emerging player.
Does Alcami have an API?
No public API is recorded for Alcami.
What industry is Alcami in?
Alcami's product category is Pharmaceutical Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO, with a secondary code of HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO. Its NAICS code is 325412 and its SIC code is 2834.